0.898  -0.152 (-14.48%)		04-24 16:00
Open: 1.04 High: 1.04 Volume: 38,663		Pre. Close: 1.05 Low: 0.898 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	1.45	1-year :	1.7
Resists	First :	1.24	Second :	1.46
Pivot price	1.17
Supports	First :	0.89	Second :	0.74
MAs	MA(5) :	1.08	MA(20) :	1.2
	MA(100) :	2.01	MA(250) :	5.6
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	8.8	D(3) :	17.4
RSI	RSI(14): 30.7
52-week	High :	17	Low :	0.89

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ LSDI ] has closed below the lower bollinger band by 12.9%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ LSDI ] is to continue within current trading range. It is unclear right now based on current values. 52.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.04 - 1.05	1.05 - 1.05
Low:	0.88 - 0.89	0.89 - 0.9
Close:	0.89 - 0.9	0.9 - 0.91

Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.

Tue, 23 Apr 2024
Scott Reeves Resigns from Lucy Scientific Discovery Board - TipRanks.com - TipRanks

Fri, 16 Feb 2024
Lucy Scientific announces reverse stock split to meet Nasdaq rules - Investing.com

Fri, 16 Feb 2024
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum ... - Business Wire

Wed, 14 Feb 2024
Lucy Scientific is running out of cash - Green Market Report

Tue, 16 Jan 2024
Lucy Scientific Offering Could Further Dilute Shares - Green Market Report

Wed, 15 Nov 2023
Lucy Scientific Burns Cash with No Revenue Collected in Q1 - Green Market Report

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	0 (M)
Shares Float	2 (M)
Held by Insiders	1.23e+006 (%)
Held by Institutions	30.3 (%)
Shares Short	16 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-8 %
Return on Assets (ttm)	906.5 %
Return on Equity (ttm)	-99.4 %
Qtrly Rev. Growth	16730 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-7.7 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	32740
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.